Peter Anevski - Jan 31, 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Jan 31, 2023
Transactions value $
-$1,308,462
Form type
4
Date filed
2/2/2023, 03:26 PM
Previous filing
Jan 5, 2023
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $2.9K +735 +0.33% $3.95* 224K Jan 31, 2023 Direct
transaction PGNY Common Stock Sale -$25.7K -735 -0.33% $35.00 223K Jan 31, 2023 Direct F1
transaction PGNY Common Stock Sale -$6.44K -184 -0.12% $35.00 156K Jan 31, 2023 See footnote F1, F2
transaction PGNY Common Stock Options Exercise $126K +32K +14.34% $3.95* 255K Feb 1, 2023 Direct
transaction PGNY Common Stock Sale -$1.12M -32K -12.54% $35.14 223K Feb 1, 2023 Direct F1, F3
transaction PGNY Common Stock Sale -$281K -8K -5.11% $35.14 148K Feb 1, 2023 See footnote F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -735 -0.05% $0.00 1.35M Jan 31, 2023 Common Stock 735 $3.95 Direct F4
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -32K -2.36% $0.00 1.32M Feb 1, 2023 Common Stock 32K $3.95 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.
F2 The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.